The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Anticoccidial Drugs Market During The Forecast Period 2026–2030?
The anticoccidial drugs market size has experienced robust growth in recent years. It is forecast to expand from $1.35 billion in 2025 to $1.45 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The growth observed in the historic period can be attributed to several factors, including the high prevalence of coccidiosis in poultry, the limited availability of effective drug classes, increasing demand for livestock products, traditional farming practices, and a growing awareness of animal health management.
The anticoccidial drugs market is projected to experience robust expansion over the coming years, with its size anticipated to reach $1.84 billion by 2030, showing a compound annual growth rate (CAGR) of 6.2%. This projected growth is driven by several factors, including advancements in drug delivery systems, the surge in intensive poultry farming, the expansion of veterinary services across developing regions, greater government backing for animal health initiatives, and the increasing worldwide consumption of meat and poultry. Furthermore, significant trends during this period are expected to encompass the creation of new anticoccidial drug formulations, a heightened emphasis on poultry health management, the growing use of combination therapies, the broadening of veterinary pharmaceutical distribution channels, and stricter regulatory adherence for veterinary medications.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp
Which Major Factors Are Driving The Expansion Of The Anticoccidial Drugs Market?
The expanding requirement for meat proteins is anticipated to fuel the growth of the anticoccidial drug market in the future. Meat proteins, which are naturally found in animal tissues, consist of various amino acids vital for numerous bodily functions. This increasing need for meat proteins stems from factors such as global population expansion, higher disposable incomes, urbanization trends, and evolving dietary preferences favoring protein-rich diets. Anticoccidial medications serve as critical instruments in contemporary livestock cultivation, assisting in preserving animal well-being and output. This ensures that producers can effectively and sustainably satisfy the rising need for meat proteins. As an illustration, in October 2025, the Meat And Livestock Australia Limited, an Australia-based non-profit organization, reported that Australia’s red meat and livestock exports saw a 3.2% year-on-year increase in 2024, reaching a total value of $19.5 billion. Consequently, the escalating demand for meat proteins is a primary impetus behind the expansion of the anticoccidial drug market.
What Market Segments Are Evaluated Within The Anticoccidial Drugs Market?
The anticoccidial drugs market covered in this report is segmented –
1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine
What Industry Trends Are Redefining The Anticoccidial Drugs Market?
Major companies within the anticoccidial drugs market are concentrating on creating advanced solutions, such as synthetic coccidiostat, to boost effectiveness, minimize the development of resistance, and tackle emerging issues in poultry and livestock management. A synthetic coccidiostat is a chemically engineered substance employed to prevent or control coccidiosis by inhibiting the proliferation and growth of coccidia parasites in animals. For example, in March 2023, Zoetis, an animal health company based in the US, introduced Avi-Deccox, a redeveloped synthetic coccidiostat aimed at managing coccidiosis in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for substantial financial losses in poultry farming. Its active ingredient is decoquinate, mirroring its earlier version, Deccox. Avi-Deccox tackles the increasing problem of resistance linked to the common application of ionophores in poultry farming by utilizing a distinct mechanism of action, thereby providing a more potent short-term knock-down effect.
Who Are The Top Market Participants Influencing The Anticoccidial Drugs Market?
Major companies operating in the anticoccidial drugs market are Zoetis Inc., Elanco Animal Health Incorporated, Huvepharma AD, Phibro Animal Health Corporation, Ceva Santé Animale S.A., Boehringer Ingelheim International GmbH, Merck & Co. Inc, Bayer AG, Virbac S.A., Vetoquinol SA, Intas Pharmaceuticals Ltd, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Biovet S.A., HIPRA, Impextraco NV, Lallemand Animal Nutrition
Read the full anticoccidial drugs market report here:
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report
Which Region Currently Holds The Largest Share Of The Anticoccidial Drugs Market?
North America was the largest region in the anticoccidial drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Anticoccidial Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15723&type=smp
Browse Through More Reports Similar to the Global Anticoccidial Drugs Market 2026, By The Business Research Company
Anticoccidial Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report
Anti Infective Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Anti Infective Drugs Market 2026
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model